Biopharma Stock Hoth Therapeutics Faces Market Volatility Hoth Therapeutics experienced a slight decline of 0.48%, closing at $1.04, with fluctuating daily highs and lows. The stock remains volatile, reflecting mixed investor sentiment. Analysts maintain optimism for long-term growth despite short-term challenges, with price targets suggesting significant upside potential for the clinical-stage biopharma company.456